Clofabosin: Difference between revisions

Jump to navigation Jump to search
m
Line 452: Line 452:
Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). In spoken Clofabosin ''-mab pegol'' is often shortened to ''-mapel'' or ''-pel''. "What" questions do ''not'' use this ending: ''Cesin gliserotin(avir)?'' = What language is this?
Yes-no questions are formed by adding the question particle ''pegol'' to the subjunctive: ''Zenazumab pegol?'' (Did he go?). In spoken Clofabosin ''-mab pegol'' is often shortened to ''-mapel'' or ''-pel''. "What" questions do ''not'' use this ending: ''Cesin gliserotin(avir)?'' = What language is this?


For realis forms (e.g. indicative, attributive, "when", "while", conjunctive), the negative marker is ''-fo-'': ''sabafovir'' 'he does not write'. For irrealis forms (e.g. subjunctive, conditional, optative, verbal noun), the negative marker is ''-tu-'': ''Sabatumab!'', ''Sabatumumab!'' or ''Sabatumomab!'' means 'Don't write!'
For realis forms (e.g. indicative, attributive, "when", "while", conjunctive), the negative marker is ''-fo-'': ''sabafovir'' 'he does not write'. For irrealis forms (e.g. subjunctive, conditional, optative, verbal noun), the negative marker is ''-tu(mo)-'': ''Sabatumab!'', ''Sabatumumab!'' or ''Sabatumomab!'' means 'Don't write!'


*'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'')
*'can' (ability) uses ''-tecan'' (inflected as if it were ''-tecavir''; the attributive is ''-taxel'')
138,977

edits

Navigation menu